Influence of age on the GH response to sumatriptan administration in man.
The present study was undertaken in order to assess the influence of aging on the serotonergic control of GH secretion in humans. For this purpose, 6 mg 5-HT1D-serotonergic receptor agonist sumatriptan (or placebo during control tests) was injected subcutaneously in a group of 9 young (26-40 yr old) and a group of 9 elderly male subjects (64-80 yr old). Sumatriptan-induced plasma GH rise was recorded during the next 2 hours. Plasma ACTH levels were also measured. The administration of the placebo was without effects in all subjects. Sumatriptan induced a striking increase in plasma GH levels in the younger group, whereas it slightly increased GH secretion in the older group (f = 9.59, p < 0.02). Plasma ACTH levels showed a similar physiological decline in all subjects during tests, regardless of sumatriptan treatment. These data show impaired serotonergic stimulatory regulation of GH secretion in elderly subjects.
Coiro
V
V
Department of Internal Medicine, University of Parma, Italy.
Volpi
R
R
Davoli
C
C
Caffarri
G
G
Chiodera
P
P
D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000502:physiology*; D013006:Growth Hormone / Q000097:blood* / Q000378:metabolism; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage / Q000494:pharmacology*; D018170:Sumatriptan / Q000008:administration & dosage / Q000494:pharmacology*
D017366:Serotonin Receptor Agonists; D018170:Sumatriptan; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone